Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, the challenging macroeconomic scenario continues to plague Globus Medical.

Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the ...

NYSE GMED opened at $76.65 on Wednesday. The firm has a market capitalization of $10.54 billion, a price-to-earnings ratio of 102.20, a PEG ratio of 1.61 and a beta of 1.19. Globus Medical, Inc ...